Cluster Headaches are accepted to be because of a blend of ecological and hereditary components. Around 66% of cases keep running in families. Changing hormone levels might likewise assume a part, as headaches influence marginally a bigger number of young men than young ladies before pubescence, yet around a few times a larger number of ladies than men. The danger of headaches more often than not declines amid pregnancy.
There are two main types of cluster headaches: Episodic cluster headaches-These occur one or more times daily for multiple weeks. The headaches then go away and come back months or years later. Chronic cluster headaches-These occur almost daily with headache-free periods lasting less than one month. A total of 250 screening-positives (0.8%) were found, of which 218 (88%) were follow-up interviewed.
The crude lifetime prevalence of Cluster Headache was higher in the twins born from 1945 to 1958 than in the twins born from 1935 to 1944 (190 vs 90/100,000). Cluster Headache recurred in 2 of 12 co-twins of monozygous index twins (including 1 nonparticipant twin), whereas all co-twins of 25 dizygous index twins proved to be unaffected. Variety of medications have been specifically designed to treat cluster headaches.
Preventive medications: These types of drugs are taken regularly, often on a daily basis, to reduce the severity or frequency of cluster headaches. The FDA is currently reviewing a new migraine drug called Trexima, which combines the migraine drug Imitrex (sumitriptan) and naproxen sodium (a nonsteroidal anti-inflammatory drug) contained in Aleve and other over-the-counter medications. The triptan prevents blood vessels from dilating.